The Cardiovascular and Cardiac Actions of Ecstasy and its Metabolites

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|11|5|470-475

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.11, Iss.5, 2010-08, pp. : 470-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electrophysiological Effects of Tiracizin and its Metabolites in Dog Cardiac Purkinje Fibers

By Nemeth M.   Varro A.   Papp J.G.  

General Pharmacology, Vol. 26, Iss. 4, 1995-07 ,pp. : 793-798

Elsevier

Access to resources Recommend Favorite

Urocortin: Cardiovascular Actions and Therapeutic Implications

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 168-172

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular actions of human urotensin II—considerations for hypertension

By Russell Fraser   Molenaar Peter  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 3, 2004-03 ,pp. : 271-273

Springer Publishing Company

Access to resources Recommend Favorite

Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 22, 2004-08 ,pp. : 2779-2786

Bentham Science Publishers

Access to resources Recommend Favorite

Survey of Secondary Plant Metabolites with Cardiovascular Activity

By Ghisalberti Emilio L.   Pennacchio Marcello   Alexander Elizabeth  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 36, Iss. 4, 1998-10 ,pp. : 237-279

Informa Healthcare

Access to resources Recommend Favorite